Megumi Furuta
5PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Sep 15, 2024
Durvalumab after chemoradiotherapy for locoregional recurrence of completely resected non-small-cell lung cancer (NEJ056).Megumi Furuta, Hidehito Horinouchi, Isao Yokota
|Jun 18, 2024
Multicenter Pharmacokinetic and Pharmacodynamic Study of Pembrolizumab for Non-small-Cell Lung Cancer in Patients Aged 75 Years and Older.Shigehiro Yagishita, Yuta Yamanaka, Takayasu Kurata
|Nov 22, 2022
Notch pathway regulates osimertinib drug-tolerant persistence in EGFR-mutated non-small-cell lung cancer.Hirofumi Takahashi, Jun Sakakibara-Konishi, Megumi Furuta
|Apr 04, 2022
Current status of first-line treatment with pembrolizumab for non-small-cell lung cancer with high PD-L1 expression.Yasuyuki Ikezawa, Hidenori Mizugaki, Ryo Morita
|Mar 16, 2019
DLL3 regulates the migration and invasion of small cell lung cancer by modulating Snail.Megumi Furuta, Hajime Kikuchi, Tetsuaki Shoji
Pageof 1
Frequent Collaborators
2 joint publications
Hidenori Mizugaki
2 joint publications
Jun Sakakibara-Konishi
2 joint publications
Hidehito Horinouchi
1 joint publications
Eiki Kikuchi
1 joint publications
Takuro Noguchi
1 joint publications
Shigehiro Yagishita
1 joint publications
Yuta Yamanaka
1 joint publications
Takayasu Kurata
1 joint publications
Kageaki Watanabe
1 joint publications
Yukio Hosomi
